PDGF-BB has been shown to upregulate the Bcl-2 family member named Myeloid Cell Leukemia-1 (Mcl-1) by forming a transcription complex between β-catenin and HIF-1α in prostate cancer cells [232]. This evidence concerns the gene HIF1A and prostate carcinoma.